People
Artios Pharma Limited announces the appointment of Tania Dimitrova as Chief Business Officer and its expanded presence in the United States.
The American Physical Society (APS) announced that Jack A. Syage PhD, and CEO of ImmunogenX, was inducted as an APS Fellow due to his outstanding contributions to physics with a special emphasis on the diversity of his original research to other fields including commercial applications benefiting humankind.
In a 56-page response to the investigation from the U.S. Food and Drug Administration, Novartis said the Kaspar brothers personally manipulated or instructed others to alter some of the preclinical data that ultimately led to the approval of the $2.1 million priced SMA therapy.
An industry first, the volunteer committee will evaluate unique patient needs and advise PRA on how clinical trials can be adapted for rare disease patients
Herbert ‘Herb’ Heyneker, Chairman of the Board of Directors at Mimetas and Dutch biotech pioneer, has been honored by the Dutch Monarchy for his contributions and commitment to biotechnology in the Netherlands and Leiden.
Biom’up SA announced that Patrice Ferrand was appointed CEO, replacing Dr. Jan Ohrstrom. Dr. Ohrstrom, who was appointed CEO in May of this year, remains Chairman of the Board, a role in which he has served for the Company since 2015.
Microsoft announced that Emma Walmsley, chief executive officer of GlaxoSmithKline, had been nominated to the company’s board of directors.
As Akcea Therapeutics moves forward with a second attempt to gain regulatory approval for Waylivra, it will do so without a number of its C-suite executives.
House Speaker Nancy Pelosi unveiled her plan to lower the prices on up to 250 prescription drugs covered by government-backed plans such as Medicare.
Pulmotect, Inc., a clinical-stage biotechnology company developing an inhaled immunomodulatory agent, is pleased to announce the appointment of Dr. Kumar Srinivasan to its Board of Directors.
PRESS RELEASES